Is the New Alzheimer’s Drug for Real?

by Dr Dharma Sing Khalsa

Is the New Alzheimer’s Drug for Real?

For the first time in over 20 years, the U.S. FDA recently approved a new drug, aducanumab, for Alzheimer’s disease, which afflicts an estimated 6 million Americans. We at the Alzheimer’s Research and Prevention Foundation (ARPF) applaud research in all levels of implementation that seek medically effective remedies for this terrible illness. Indeed, patients, their families, caregivers and the medical profession are in dire need of good news so that our communities may be spared from further devastation by Alzheimer’s.